Boothbay Fund Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,004
Closed -$315K 1449
2024
Q3
$315K Buy
+3,004
New +$351K 0.01% 1209
2023
Q4
Sell
-5,727
Closed -$934K 1615
2023
Q3
$934K Buy
5,727
+1,457
+34% +$256K 0.02% 797
2023
Q2
$783K Buy
+4,270
New +$615K 0.02% 933
2021
Q3
Sell
-14,013
Closed -$566K 1858
2021
Q2
$566K Buy
14,013
+4,548
+48% +$188K 0.02% 944
2021
Q1
$389K Buy
+9,465
New +$353K 0.01% 1078

Other funds holding ACLS

Boothbay Fund Management's ACLS Position: Q4 2024 in Review

Boothbay Fund Management sold out of Axcelis (ACLS) in Q4 2024, closing a stake of 3,004 shares — an estimated $315K sold.

Boothbay Fund Management first reported a position in ACLS in Q1 2021 and held it in 5 quarters. The position peaked at $934K in Q3 2023. 324 funds tracked by Wall St. Rank hold ACLS as of Q4 2024.

  • Boothbay Fund Management reported no remaining Axcelis position as of Q4 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 3,004 Axcelis shares in Q4 2024, an estimated $315K.
  • Boothbay Fund Management first reported a position in Axcelis in Q1 2021 and held it in 5 quarters.
  • Boothbay Fund Management's Axcelis position peaked at $934K in Q3 2023.
  • 324 funds tracked by Wall St. Rank held Axcelis as of Q4 2024.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.